£4.5M Investment Led by Confluent Medical

Proceeds to be used to expand electrospinning capabilities & capacity, driving company growth    Harwell, UK, May 4 2021 – The Electrospinning Company (Electrospinning), a leader in the development and manufacture of nanofibrous biomaterials for use in tissue regenerative devices, has completed a £4.5m ($6.3m) fundraising round, led by US materials science company Confluent Medical Technologies Inc. (Confluent) as a strategic investor…. Read more »

The Electrospinning Company and Avem Market Solutions partner to bring Electrospinning’s biomaterials to the medical device industry.

The Electrospinning Company, a leading innovator in nanofibrous biomaterials for medical devices, has announced a strategic partnership with Avem Market Solutions to bring its advanced products to a broader range of medical device customers. This collaboration will combine Electrospinning’s cutting-edge biomaterials with Avem’s deep industry expertise to accelerate the development and commercialisation of differentiated medical… Read more »

AAOS 2024, 13-15 February San Francisco

The Electrospinning Company will once again exhibit at the AAOS 2024 in San Francisco, US, from 13th to 15th of February.  You are welcome to visit our booth #864 and find out more about our innovative technology. Our CEO, Ann Kramer, Sen. Director of Bus. Dev. North America Jeff Orosco, Head of Business Development, Marco… Read more »

Congratulations Dr. Sahay!

We congratulate Dr. Priti Sahay (right) from the University of Nottingham with winning the David Meyer Research Price 2024. Dr. Sahay presented her work on our Symatix Membrane at the The European Vision & Eye Research Association 2023 and Nottingham Eye Symposium. Her work is published in Acta Ophthalmologica and can be found here About… Read more »

Biosynthetic Soft Tissue Regeneration Membrane

The Electrospinning Company is excited to announce the development of the second Symatix Technology material. Next to our Symatix Membrane, the world’s first amniotic membrane substitute for ocular surface regeneration, we have started development of a proprietary membrane for use in soft tissue regeneration. The membrane comprises of a synthetic nonwoven structure enriched by medical… Read more »

AWRE 2024, 31 Jan – Feb 1 Ghent, Belgium

The Electrospinning Company will be attending the  AWRE 2024 in Ghent, Belgium, between the 31st and 1st of February.  Our Head of Business Development, Marco Thio, and Senior Scientist Giulia Creed are glad to share their insights into non-woven solutions in abdominal wall reconstruction using electrospinning technology. Book a meeting with them at: info@electrospinning.co.uk